BCR-ABL kinase domain mutations, including 2 novel mutations in imatinib resistant Malaysian chronic myeloid leukemia patients—Frequency and clinical outcome-Reference-Cited by-同舟云学术

BCR-ABL kinase domain mutations, including 2 novel mutations in imatinib resistant Malaysian chronic myeloid leukemia patients—Frequency and clinical outcome

Published:2014-04 Issue:4 Volume:38 Page:454-459
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Elias Marjanu Hikmah,Baba Abdul Aziz,Azlan Husin,Rosline Hassan,Sim Goh Ai,Padmini Menon,Fadilah S. Abdul Wahid,Ankathil Ravindran

Funder

This study was partly supported by Universiti Sains Malaysia – Research University Grant (USM-RU)

Fundamental Research Grant Scheme (FRGS)

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference26 articles.

1. Molecular targeted treatment – new treatment strategy for patients with chronic myeloid leukemia;Usui;Rinsho Byori,2004

2. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia;Druker;N Engl J Med,2006

3. Association between imatinib-resistant BCR-ABL mutation-negative leukemia and persistent activation of LYN kinase;Wu;J Natl Cancer Inst,2008

4. Frequency and clinical significance of BCR-ABL mutations in patients with chronic myeloid leukemia treated with imatinib mesylate;Jabbour;Leukemia,2006

5. Contribution of BCR-ABL kinase domain mutations to imatinib mesylate resistance in Philadelphia chromosome positive Malaysian chronic myeloid leukemia patients;Elias;Hematol Rep,2012

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural compounds combined with imatinib as promising antileukemic therapy: An updated review;Fitoterapia;2024-10

2. Significance of Somatic Mutation Profiling in CML Beyond BCR-ABL: A Retrospective Study of the Indian Population;Indian Journal of Hematology and Blood Transfusion;2024-06-21

3. Mutation analysis of BCR-ABL1 kinase domain in chronic myeloid leukemia patients with tyrosine kinase inhibitors resistance: a Malaysian cohort study;BMC Research Notes;2024-04-20

4. Investigation of the mechanism of USP28-mediated IFITM3 elevation in BCR-ABL-dependent imatinib resistance in CML;Biomedicine & Pharmacotherapy;2024-04

5. Frequencies of BCR::ABL1 Transcripts in Patients with Chronic Myeloid Leukemia: A Meta-Analysis;Genes;2024-02-12